AG
Anton Gueth
Director

Anton Gueth insider trades: Antares Pharma (ATRS) stock buys and sales

Director, Antares Pharma Last trade Jul 8, 2021 37 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2009
5
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Anton reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 8, 2021ATRS↓ Sell$429K
Mar 18, 2016ATRS↑ Buy$36K
Aug 11, 2014ATRS↑ Buy$10K
Sep 3, 2013ATRS↓ Sell$111K
Aug 1, 2013ATRS↓ Sell$110K
Jul 1, 2013ATRS↓ Sell$104K
Jun 3, 2013ATRS↓ Sell$100K
May 30, 2012AIS↓ Sell$249K
Sep 27, 2010AIS↑ Buy$11K
May 15, 2009AIS↑ Buy$600

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Anton Gueth's insider trades

Anton Gueth is a director at Antares Pharma (ATRS). Since May 15, 2009, Anton has reported 4 open-market purchases worth $58K and 6 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (23 filings), option exercises (5 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.